(Q42006361)

English

Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects

scientific article

Statements

Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects (English)
Albrecht Stoehr
Kimberly Manhard
Vijay Hingorani

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit